15/09/25 DiaMonTech AG announced that it has received ?8 million in funding from Samsung NEXT, LLC CI
25/11/24 DiaMonTech AG announced that it has received funding from Disrupt Health Impact Fund CI
06/12/23 DiaMonTech AG announced that it has received funding from Moll Family GmbH, and other investors CI
16/02/22 DiaMonTech AG announced that it has received $5 million in funding from IBB Beteiligungsgesellschaft mbH, Unorthodox Ventures, Samsung Venture Investment Corporation CI
26/11/19 DiaMonTech AG has withdrawn its IPO in the amount of €59.375 million. CI
25/11/19 DAK-Gesundheit and DiaMonTech AG Plan Strategic Cooperation in the Non-Invasive Blood Glucose Monitoring Sector for New Treatment Strategies in the Diabetes Sector CI
13/11/19 DiaMonTech AG has filed an IPO in the amount of €59.375 million. CI
11/11/19 DiaMonTech AG Signs A Further Agreement with an International Sales Company CI
21/10/19 DiaMonTech GmbH Publishes Results of Clinical Study Confirming the Accuracy of its Non-Invasive Blood Glucose-Monitoring Technology CI
01/10/19 DiaMonTech GmbH Appoints Enrico Just as Managing Director and CFO CI
16/09/19 Deutscher Apothekerverband e. V. & DiaMonTech GmbH Intends Strategic Cooperation to Significantly Improve the Care of Diabetes Patients and to Take an Innovative Step into the Future CI
08/09/19 DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors CI
04/09/18 DiaMonTech GmbH announced that it has received funding from IBB Beteiligungsgesellschaft mbH, Macnica, Inc., Jindong Investment Group Co., Ltd. CI
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 09/01/2015
Chief Executive Officer 52 31/03/2015
Director of Finance/CFO - 30/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.62%-1.87%+42.87%+64.15% 63.77B
+0.35%+3.20%+14.40%+81.76% 56.37B
+0.53%+1.96%+16.24%+103.35% 54.62B
-2.81%-4.31%+23.50%+47.83% 44.06B
-0.33%-1.93%+19.28%+98.80% 42.11B
+0.55%+2.31%+225.14%+866.21% 41B
+3.27%+47.96%+112.84%+96.58% 34.92B
+1.22%-1.44%+14.57%+46.95% 32.82B
+0.89%+20.55%-40.62%+349.24% 24.7B
Average +0.31%+7.54%+47.58%+194.99% 43.82B
Weighted average by Cap. +0.18%+5.44%+47.99%+176.67%
Logo DiaMonTech AG
DiaMonTech AG is a Germany-based medical device company. It develops a device for non-invasive measuring of glucose levels in diabetes patients. The device is based on spectroscopy and uses photothermal detection technology. The device range under development includes a desktop device for clinical settings and multiple users, as well as a compact pocket device for the end user.
Employees
-